comparemela.com

Michael Halstead, EVP and General Counsel of Intra-Cellular Therapies Inc (NASDAQ:ITCI), has sold 7,907 shares of the company on February 26, 2024, according to a recent SEC Filing.

Related Keywords

,Cellular Therapies Inc ,Intra Cellular Therapies Inc ,Possible Value Trap ,Think Twice ,Iopharmaceutical Company ,Michael Halstead ,Neurological Disorders ,Central Nervous System Disorders ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.